OpGen Announces Execution of Reverse Stock Split
OpGen (NASDAQ:OPGN) announced today that it will implement a 1-for-25 reverse stock split of its common stock. The Company filed...
Amicus Therapeutics Launches Treatment of Fabry Disease in Spain
Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch...
Strongbridge Biopharma Receives Notice of Allowance from U.S. Patent and Trademark Office for New Patent
Strongbridge Biopharma (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with...
Celsion Corporation Provides Corporate Update and 2018 Outlook
Celsion Corporation (NASDAQ:CLSN), an oncology drug development company, today provided a year-end 2017 corporate review and announced clinical progress for two...
Argos Announces One-for-Twenty Reverse Stock Split
Argos Therapeutics (NASDAQ:ARGS) an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis® precision...
RepliCel Life Sciences Lands Commitment for Key Investment Partnership
RepliCel Life Sciences (TSX:RP), announced it has signed a Binding Term Sheet with YOFOTO (China) Health Industry Co. to form...
IP veteran Andrew Filler joins BioSig Technologies’ Board of Directors
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an...
DelMar Pharmaceuticals Appoints Saiid Zarrabian as Interim Chief Executive Officer
DelMar Pharmaceuticals, Inc. (Nasdaq:DMPI) ("DelMar" and "the Company"), a biopharmaceutical company focused on the development of new cancer therapies, today...
3D Signatures Announces Close of Private Placement With Strategic Partner and Prospectus Update
3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or “3DS”) is pleased to announce the close of its non-brokered private...
EVIO Engages NetworkNewsWire for Corporate Communications Solutions
EVIO (OTCQB:EVIO) has announced it has engaged the corporate communications expertise of NetworkNewsWire. As quoted in the press release: “In...